Effectiveness of Discrete Strategies and Implementation Bundles for Improving Clinician Prescription of Clinical Practice Guideline–Recommended Medications for Atherosclerotic Occlusive Disease: A Systematic Review and Meta‐Analysis
5 affiliations
- 1University of Ottawa
- 2The Ottawa Hospital Research Institute, The Ottawa Hospital
- 3University of Ottawa and The Ottawa Hospital
- 4Institute for Clinical Evaluative Sciences
- 5The Ottawa Hospital
Abstract
Background We sought to determine the effectiveness of discrete strategies and implementation bundles for improving clinical practice guideline (CPG) strongly recommended medication prescription to adults with atherosclerotic occlusive disease. Methods We searched MEDLINE, Embase, Cochrane Central Register of Controlled Trials, PsycINFO, and Cumulative Index to Nursing and Allied Health Literature (inception to December 9, 2025) for randomized controlled trials evaluating discrete strategies or implementation bundles for improving CPG strongly recommended medication prescription to adults with atherosclerotic occlusive disease. Two investigators screened titles/abstracts and full texts, extracted data, assessed risk of bias, and classified discrete strategies and implementation bundles. Random‐effects models were used for meta‐analysis. Grading of Recommendations Assessment, Development and Evaluation was used to assess certainty. Results We included 31 randomized controlled trials studying 29 unique discrete strategies and implementation bundles. The implementation bundle with the largest effect size for improving CPG strongly recommended medication prescription combined case management, team changes, continuous quality improvement, audit/feedback, and clinician and patient education (relative risk, 2.62 [95% CI, 2.08–3.29]; moderate certainty). Meta‐regression analyses suggested that discrete strategies and implementation bundles using patient education were more effective at improving statin ( P =0.037) and all CPG strongly recommended medication ( P =0.006) prescription. Combining case management, team changes, facilitated relay of information, and audit/feedback reduced all‐cause death and new vascular event risk. Team changes improved prescription of all CPG strongly recommended medications (relative risk, 1.23 [95% CI, 1.11–1.36]; moderate certainty) and reduced major adverse cardiac event risk. Conclusions Combining case management, team changes, continuous quality improvement, audit/feedback, and clinician and patient education had the largest effect size for improving CPG strongly recommended medication prescription and improved patient outcomes. Team changes improved CPG strongly recommended medication prescription and reduced major adverse cardiac event risk.
Related
- Time-to-Statin Prescription for Primary Atherosclerotic Cardiovascular Disease Prevention in a Lung Cancer Screening Program in Missouri: A Retrospective Cohort Study
- Cost-effectiveness of recommended interventions for managing low back pain: A systematic review
- IDENTIFYING BARRIERS TO THE IMPLEMENTATION OF RECOMMENDED TESTING GUIDELINES IN CHRONIC LYMPHOCYTIC LEUKEMIA: A DELPHI SURVEY IN LATIN AMERICA
- Effectiveness of a Physical Exercise Prescription Program in Primary Care to Improve Physical Fitness and Quality of Life in Adults Aged 65 Years and Older in a Rural Basic Health Area-Study Protocol for a Randomized Controlled Trial (PREFIS-AP).
- Long-term abortion and birth rates for 14- to 25-year-olds before and after the implementation of prescription-free emergency contraceptives in Finland
BibTeX
@article{kirkham2026effectiveness,
title = {{Effectiveness of Discrete Strategies and Implementation Bundles for Improving Clinician Prescription of Clinical Practice Guideline–Recommended Medications for Atherosclerotic Occlusive Disease: A Systematic Review and Meta‐Analysis}},
author = {Aidan M. Kirkham and Jasmine Candeliere and Justin Presseau and Daniel I. McIsaac and Risa Shorr and Dean A. Fergusson and Derek J. Roberts},
journal = {Journal of the American Heart Association},
year = {2026},
month = oct,
doi = {10.1161/jaha.126.052304},
url = {https://www.ahajournals.org/doi/10.1161/JAHA.126.052304},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Effectiveness of Discrete Strategies and Implementation Bundles for Improving Clinician Prescription of Clinical Practice Guideline–Recommended Medications for Atherosclerotic Occlusive Disease: A Systematic Review and Meta‐Analysis
AU - Aidan M. Kirkham
AU - Jasmine Candeliere
AU - Justin Presseau
AU - Daniel I. McIsaac
AU - Risa Shorr
AU - Dean A. Fergusson
AU - Derek J. Roberts
PY - 2026
DA - 2026/10/20
JO - Journal of the American Heart Association
DO - 10.1161/jaha.126.052304
UR - https://www.ahajournals.org/doi/10.1161/JAHA.126.052304
AB - Background We sought to determine the effectiveness of discrete strategies and implementation bundles for improving clinical practice guideline (CPG) strongly recommended medication prescription to adults with atherosclerotic occlusive disease. Methods We searched MEDLINE, Embase, Cochrane Central Register of Controlled Trials, PsycINFO, and Cumulative Index to Nursing and Allied Health Literature (inception to December 9, 2025) for randomized controlled trials evaluating discrete strategies or implementation bundles for improving CPG strongly recommended medication prescription to adults with atherosclerotic occlusive disease. Two investigators screened titles/abstracts and full texts, extracted data, assessed risk of bias, and classified discrete strategies and implementation bundles. Random‐effects models were used for meta‐analysis. Grading of Recommendations Assessment, Development and Evaluation was used to assess certainty. Results We included 31 randomized controlled trials studying 29 unique discrete strategies and implementation bundles. The implementation bundle with the largest effect size for improving CPG strongly recommended medication prescription combined case management, team changes, continuous quality improvement, audit/feedback, and clinician and patient education (relative risk, 2.62 [95% CI, 2.08–3.29]; moderate certainty). Meta‐regression analyses suggested that discrete strategies and implementation bundles using patient education were more effective at improving statin ( P =0.037) and all CPG strongly recommended medication ( P =0.006) prescription. Combining case management, team changes, facilitated relay of information, and audit/feedback reduced all‐cause death and new vascular event risk. Team changes improved prescription of all CPG strongly recommended medications (relative risk, 1.23 [95% CI, 1.11–1.36]; moderate certainty) and reduced major adverse cardiac event risk. Conclusions Combining case management, team changes, continuous quality improvement, audit/feedback, and clinician and patient education had the largest effect size for improving CPG strongly recommended medication prescription and improved patient outcomes. Team changes improved CPG strongly recommended medication prescription and reduced major adverse cardiac event risk.
SN - 2047-9980
ER -